Sign in
Not yet taking people in United StatesNo phase

Intermittent Fasting for Pancreatitis

Key facts

Who runs it
H. Lee Moffitt Cancer Center and Research Institute
Where
Tampa, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
64 people, planned
Starts
Sept 2027
Expected to end
Mar 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Intermittent Fasting
  • No intermittent fasting
Record updated
17 September 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Age ≥ 18 year
  • Recurrent acute pancreatitis defined by greater than 2 episodes of pancreatitis, defined by:; abdominal pain and either amylase or lipase > 3 x the upper limit of normal, imaging suggestive of, separated by time
  • Anatomy of chronic pancreatitis defined by Rosemont criterion9 or on imaging (CT, MRI)
  • Pancreatic exocrine insufficiency defined by a pancreatic elastase < 200 ug/g stool10

Who cannot take part

  • Glycogen storage disease
  • Patients with diabetes
  • Age < 18 years
  • Age > 80 years
  • Pregnant Patients
  • Patients who cannot consent for themselves
  • Insulinoma or hypoglycemic state
  • Active alcohol abuse
  • Alcohol induced acute pancreatitis
  • Gallstone induced acute pancreatitis
  • Pancreatic solid neoplasm
  • Patients on beta blockers

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Where in United States

  • Moffitt Cancer CenterTampa, United StatesContact: Shaffer Mok, MDNot yet recruiting

About the trial

What the trial wants to find out

The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.

The 2 groups in the trial

  • Intermittent FastingTreatment being tested

    Patients in Group A will then receive information regarding intermittent fasting, which would include fasting for a 16-hour period each day, followed by ingestion of an appropriate number of calories for the remaining part of the day.

  • ControlExisting treatment, for comparison

    These subjects will undergo standard caloric dietary guidance. Patients in group B will also be given the above information, though not be asked to intermittently fast.

    Treatment: No intermittent fasting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Intermittent Fasting as a Primary Means for Improving Quality of Life for Acute and Chronic Pancreatitis
Criteria questions
Built from NCT04760847, who can take part
Record updated
17 September 2026